ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Correlation between platelets count and NLR (neutrophil lymphocyte ratio) on CRP (C-reactive protein) in COVID-19 patients in Jember regency

21st European Pathology Congress

Rini Riyanti

University of Jember, Indonesia

ScientificTracks Abstracts: J Clin Exp Pathol

Abstract
Statement of the Problem: COVID-19 has varied clinical manifestations and prognoses. Many factors influence clinical manifestations and prognosis in COVID-19 patients, including sex, age, comorbidities, immune status, variant of SARS-CoV-2 and therapy. Quick response is needed by health workers when dealing with COVID-19 patients. In Indonesia, as a developing country, PCR examination takes 24 hours. Therefore, establishing a temporary diagnosis from a history of infection, sign, symptom and simple laboratory examination are the first things to do when the COVID-19 patient comes to the emergency room. In addition, it is also necessary to determine the prognosis when they first arrived to be able to provide adequate treatment. CRP (C-reactive protein) is acute phase reactant protein that can predict the severity of COVID-19 patients. Beside that, viral infections can affect several hematologic markers. Therefore, it is necessary to evaluate hematologic markers in COVID-19 patients when they first come to the emergency room. The purpose of this study was to determine the relationship between platelets count and NLR (neutrophil lymphocyte ratio) on CRP (C-reactive protein) in COVID-19 patients in Jember regency. Methodology & Theoretical Orientation: This study used an observational analysis approach using secondary data from COVID-19 patient�s medical records. Using platelets count, NLR and CRP of COVID-19 patients from June to August 2021. Of the 30 patients who were research subjects, 23 were treated in non-ICU rooms and 7 were treated in ICU rooms. Findings: Pearson analysis results for correlation between platelets counts with CRP and NLR with CRP obtained p = 0.001, r = -0.733 and p = 0.000, r = 0.889, respectively. Conclusion & Significance: There is strong negative correlation between platelets count and CRP. In addition, there is a very strong positive correlation between NLR and CRP. The correlation between platelets count and NLR on CRP are related to prognostic and predictive factors of severity in COVID-19 patients. Platelet counts and NLR can replace CRP as a marker to predict severity in patients diagnosed with COVID-19.
Biography

Rini Riyanti has expertise in clinical pathology and is interested in studying the clinical and laboratory aspects of COVID-19. She is a teaching staff at the Faculty of Medicine, University of Jember. During the COVID-19 Pandemic, She worked in a clinical pathology laboratory that carry out laboratory tests and PCR tests for COVID-19 patients.

Top